K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

0
Player Avatar Sagemanx (43.82) Submitted: 5/30/2011 1:17:45 AM : Outperform Start Price: $3.32 KV-A Score: -58.26

Looks like a bounce from here...

Featured Broker Partners


Advertisement